 |
40 Products |  |
109 Diseases | | 40 Products |
|
37 Trials |  |
1902 News |  |
| «12...891011121314151617181920 |
- | Gemiglo (gemigliptin) / Sanofi, LG Chem
Trial completion: Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects (clinicaltrials.gov) - Dec 28, 2011
P1, N=30, Completed, Sponsor: LG Life Sciences
Recruiting --> Completed
- ||||| Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
New P2 trial, Combination therapy, Metastases: A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy (clinicaltrials.gov) - Nov 21, 2011
P2, N=265, Active, not recruiting, Sponsor: Astellas Pharma Inc
- Euvax B (recombinant hepatitis B vaccine) / LG Chem
Clinical: Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients (clinicaltrials.gov) - Oct 26, 2011
P=N/A, N=51, Completed, Sponsor: Tehran University of Medical Sciences
- | Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem
Trial completion, Metastases: A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Sep 22, 2011
P1, N=50, Completed, Sponsor: AVEO Pharmaceuticals, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- | Gemiglo (gemigliptin) / Sanofi, LG Chem
New P1 trial: Pharmacokinetic Drug Interaction Study in Healthy Male Subjects (clinicaltrials.gov) - Aug 30, 2011
P1, N=24, Completed, Sponsor: LG Life Sciences
- | Besivo (besifovir) / Gilead, LG Chem, Ildong
New P1 trial: Bioequivalence of LB80380 Free Base and Maleate Salt Tablets (clinicaltrials.gov) - Aug 24, 2011
P1, N=32, Completed, Sponsor: LG Life Sciences
- | Gemiglo (gemigliptin) / Sanofi, LG Chem
New P1 trial: Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects (clinicaltrials.gov) - Aug 21, 2011
P1, N=30, Completed, Sponsor: LG Life Sciences